Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.

Calvete, Oriol; Mestre, Julia; Risueño, Ruth M; Manzanares, Ana; Acha, Pamela; Xicoy, Blanca; Solé, Francesc

Calvete, Oriol; Mestre, Julia; Risueño, Ruth M; Manzanares, Ana; Acha, Pamela; Xicoy, Blanca; Solé, Francesc.

Afiliação

Calvete O; MDS Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Mestre J; MDS Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Risueño RM; Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Manzanares A; Leukos Biotech, 08021 Barcelona, Spain.
Acha P; Faculty of Education, University of Atlántico Medio, 35017 Las Palmas, Spain.
Xicoy B; MDS Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Solé F; MDS Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.

Biomedicines ; 11(12)2023 Dec 05.

Article em En | MEDLINE | ID: mdl-38137443

Palavras-chave

genetic predisposition; genomic screening; germline variants; multiplexed samples; myelodysplastic syndromes (MDS); targeted next-generation sequencing (tNGS)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article